Marc H.V. van Regenmortel, Ph.D.

home / authors / marc-hv-van-regenmortel-phd

Articles

Immunogenicity of Biopharmaceuticals: An Example from Erythropoietin

Immunogenicity of Biopharmaceuticals: An Example from Erythropoietin

Katia Boven, M.D.;Fred Bader, Ph.D.;Marc H.V. van Regenmortel, Ph.D.

August 1st 2005

Subcutaneous administration is likely to be an important factor in generating an immunogenic response.

Latest Updated Articles

Exploring New Advancements in ADC Technologies (CPHI Milan 2024)

Published: October 11th 2024 | Updated: March 3rd 2025

Exploring New Advancements in ADC Technologies (CPHI Milan 2024)

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

Published: September 11th 2024 | Updated: September 18th 2024

CPHI Pharma Award Finalists Announced for 2024

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Published: March 27th 2024 | Updated: June 28th 2024

AbbVie Acquires Landos Biopharma and Gets Full FDA Nod for ADC Product

BIO 2025: Speeding Up Development of Next-Generation Biologics

Published: June 23rd 2025 | Updated: July 2nd 2025

BIO 2025: Speeding Up Development of Next-Generation Biologics

Published: July 20th 2020 | Updated: July 2nd 2025

Contact BioPharm International Editors

BIO 2025: Building Relationships Amid a Rebrand

Published: June 19th 2025 | Updated: July 2nd 2025

BIO 2025: Building Relationships Amid a Rebrand

Editorial Information

Do Not Sell My Personal Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences

All rights reserved.